Fluorescence in-situ hybridization method based on cell slide
Through the fluorescence in situ hybridization method based on cell crawlers, experimental steps and equipment requirements are simplified, high cost and low efficiency problems in traditional technologies are solved, and accurate localization of oligonucleotides in cells and efficient research support are achieved.
Patent Information
- Application Number
- CN202411414895.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-11
- Publication Date
- 2024-12-06
AI Technical Summary
Traditional fluorescence in-situ hybridization technology requires expensive equipment and complex consumables, and the operation steps are cumbersome, resulting in high experimental costs and low efficiency, limiting its wide application in related fields.
Using fluorescent in situ hybridization method based on cell crawlers, the localization of oligonucleotides in cells is achieved through simple equipment, including cell seeding, washing, fixation, permeability, pre-hybridization, hybridization, washing and blocking, antibody incubation and observation With the analysis steps, the dependence on expensive equipment and consumables is avoided.
It reduces the cost of experiments, simplifies operational steps, improves experimental efficiency, and more accurately explores the localization of oligonucleotides in cells by optimizing conditions, supporting research in related fields.
Smart Images

Figure CN119082271A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of molecular cytogenetics, and specifically is a method for establishing a fluorescence in situ hybridization reaction system using cell slides and oligonucleotide probes, aiming to explore the localization of oligonucleotides in cells and provide a simpler, more economical and efficient experimental means for research in related fields. Background Art
[0002] Traditional fluorescence in situ hybridization technology relies on expensive in situ hybridization boxes and other complex consumables, and the operation steps are cumbersome, which brings great inconvenience to the experimenters. In addition, the high experimental cost also limits the promotion of this technology in a wide range of applications. Therefore, there is an urgent need for a simpler, more economical and efficient fluorescence in situ hybridization method to meet the urgent needs of research in related fields. Summary of the invention
[0003] The purpose of the present invention is to provide a fluorescent in situ hybridization method based on cell slides, which can realize the localization exploration of oligonucleotides in cells with simple equipment, without the need for special hybridization box equipment and other complex consumables, greatly reducing the experimental cost, simplifying the operation steps, and improving the experimental efficiency.
[0004] To achieve the above object, the present invention provides the following technical solutions:
[0005] A fluorescence in situ hybridization method based on cell slides comprises the following specific steps:
[0006] Step S1:
[0007] Cell seeding: Inoculate cells in a 12-well cell plate covered with a round glass slide in advance; for primary cells, perform cell sorting one day in advance and then seed them in a 12-well cell plate;
[0008] Step S2:
[0009] Washing: The next day, discard the cell culture medium and slowly wash with 0.1% PBST three times, 5 minutes each time, to remove impurities and residues on the cell surface;
[0010] Step S3:
[0011] Fixation: Add 4% PFA for 30 minutes, then discard the 4% PFA and wash three times with 0.1% PBST for 5 minutes each time to fix the cell morphology;
[0012] Step S4:
[0013] Permeabilization: Add 0.3% Triton X-100 for 20 minutes, then discard 0.3% Triton X-100 and wash with 0.1% PBST for 3 times, 5 minutes each time, to allow the probe to enter the cells smoothly;
[0014] Step S5:
[0015] Prehybridization: Add HYB- and incubate at 55°C for 5 minutes to remove nonspecific binding sites in the cells;
[0016] Step S6:
[0017] Hybridization: discard HYB-, add HYB+, incubate at 55°C for 3 hours, then add the probe prepared with HYB+, incubate at 55°C overnight to allow the probe to specifically bind to the target sequence in the cell;
[0018] Step S7:
[0019] Washing and sealing
[0020] The next day, the probe was recovered, 50% acetamide-2×SSCT was added, and the mixture was incubated at 55°C for 30 minutes, and the process was repeated once; 2×SSCT was then incubated at 55°C for 15 minutes; 0.2×SSCT was added, and the mixture was incubated at 55°C for 30 minutes, and the process was repeated once;
[0021] Blocking: Add 2% goat serum and block at room temperature for 15 minutes to block nonspecific binding sites;
[0022] Step S8:
[0023] Antibody incubation
[0024] Primary antibody incubation: Add primary antibody prepared with 2% goat serum and incubate overnight at 26 rpm on a shaker at 4°C. The next day, take out the sample in advance and equilibrate and rewarm for 10 minutes.
[0025] Recovery of primary antibody: After recovery of primary antibody, wash three times with 0.1% PBST, 10 minutes each time;
[0026] Secondary antibody incubation: Dilute the corresponding host-derived fluorescent secondary antigen solution, DAPI and 2% goat serum according to the ratio specified in the instructions, mix well and add to the sample wells, and incubate at room temperature on a light-proof shaker at 26 rpm for 2 hours;
[0027] Step S9:
[0028] Washing and sealing: After recovering the secondary antibody, wash with 0.1% PBST for 3 times, 10 minutes each time; add anti-quenching agent for sealing to protect the sample and prevent fluorescence quenching;
[0029] Step S10:
[0030] Observation and analysis: Observation at different magnifications under a fluorescence microscope, and image acquisition and analysis were performed to determine the localization of the oligonucleotides in the cells.
[0031] Compared with the prior art, the present invention has the following significant advantages:
[0032] 1. Reduce costs: The present invention does not require the use of expensive in situ hybridization boxes and other complex consumables, which greatly reduces the experimental costs;
[0033] 2. Simplified steps: The operation steps of the present invention are relatively simple, without the need for cumbersome experimental steps and complex equipment support, thus improving experimental efficiency;
[0034] 3. Improve accuracy: By optimizing experimental conditions, the present invention can more accurately explore the localization of oligonucleotides in cells and provide strong support for research in related fields. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figure 1 The present invention is a flow chart of a fluorescence in situ hybridization method based on cell slides. DETAILED DESCRIPTION
[0036] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Generally, the components of the embodiments of the present invention described and shown in the drawings here can be arranged and designed in various different configurations.
[0037] In the description of the embodiments of the present invention, it should be noted that if the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer", etc. appear, the orientation or position relationship indicated is based on the orientation or position relationship shown in the drawings, or the orientation or position relationship in which the invented product is usually placed when used. It is only for the convenience of describing the present invention and simplifying the description, and does not indicate or imply that the device or element referred to must have a specific orientation, be constructed and operate in a specific orientation, and therefore cannot be understood as a limitation on the present invention. In addition, the terms "first", "second", "third", etc. are only used to distinguish the description, and cannot be understood as indicating or implying relative importance.
[0038] In addition, the terms "horizontal", "vertical", "overhanging" and the like do not mean that the components must be absolutely horizontal or overhanging, but can be slightly tilted. For example, "horizontal" only means that its direction is more horizontal than "vertical", and does not mean that the structure must be completely horizontal, but can be slightly tilted.
[0039] In the description of the embodiments of the present invention, "plurality" means at least 2.
[0040] In the description of the embodiments of the present invention, it is also necessary to explain that, unless otherwise clearly specified and limited, the terms "set", "install", "connect", and "connect" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection, or it can be indirectly connected through an intermediate medium, or it can be the internal connection of two components. For ordinary technicians in this field, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.
[0041] Example:
[0042] The present invention inoculates cells in a 12-well cell plate that has been covered with a circular glass slide, and performs steps such as washing, fixation, permeabilization, pre-hybridization, hybridization, washing and blocking, antibody incubation, washing and sealing, and observation and analysis. Through fluorescence microscopy observation, the localization of oligonucleotides in cells is successfully explored.
[0043] The specific plan is as follows:
[0044] A fluorescence in situ hybridization method based on cell slides comprises the following specific steps:
[0045] Step S1:
[0046] Cell seeding: Inoculate cells in a 12-well cell plate covered with a round glass slide in advance; for primary cells, perform cell sorting one day in advance and then seed them in a 12-well cell plate;
[0047] Step S2:
[0048] Washing: The next day, discard the cell culture medium and slowly wash with 0.1% PBST three times, 5 minutes each time, to remove impurities and residues on the cell surface;
[0049] Step S3:
[0050] Fixation: Add 4% PFA for 30 minutes, then discard the 4% PFA and wash three times with 0.1% PBST for 5 minutes each time to fix the cell morphology;
[0051] Step S4:
[0052] Permeabilization: Add 0.3% Triton X-100 for 20 minutes, then discard 0.3% Triton X-100 and wash with 0.1% PBST for 3 times, 5 minutes each time, to allow the probe to enter the cells smoothly;
[0053] Step S5:
[0054] Prehybridization: Add HYB- and incubate at 55°C for 5 minutes to remove nonspecific binding sites in the cells;
[0055] Step S6:
[0056] Hybridization: discard HYB-, add HYB+, incubate at 55°C for 3 hours, then add the probe prepared with HYB+, incubate at 55°C overnight to allow the probe to specifically bind to the target sequence in the cell;
[0057] Step S7:
[0058] Washing and sealing
[0059] The next day, the probe was recovered, 50% acetamide-2×SSCT was added, and the mixture was incubated at 55°C for 30 minutes, and the process was repeated once; 2×SSCT was then incubated at 55°C for 15 minutes; 0.2×SSCT was added, and the mixture was incubated at 55°C for 30 minutes, and the process was repeated once;
[0060] Blocking: Add 2% goat serum and block at room temperature for 15 minutes to block nonspecific binding sites;
[0061] Step S8:
[0062] Antibody incubation
[0063] Primary antibody incubation: Add primary antibody prepared with 2% goat serum and incubate overnight at 26 rpm on a shaker at 4°C. The next day, take out the sample in advance and equilibrate and rewarm for 10 minutes.
[0064] Recovery of primary antibody: After recovery of primary antibody, wash three times with 0.1% PBST, 10 minutes each time;
[0065] Secondary antibody incubation: Dilute the corresponding host-derived fluorescent secondary antigen solution, DAPI and 2% goat serum according to the ratio specified in the instructions, mix well and add to the sample wells, and incubate at room temperature on a light-proof shaker at 26 rpm for 2 hours;
[0066] Step S9:
[0067] Washing and sealing: After recovering the secondary antibody, wash with 0.1% PBST for 3 times, 10 minutes each time; add anti-quenching agent for sealing to protect the sample and prevent fluorescence quenching;
[0068] Step S10:
[0069] Observation and analysis: Observation at different magnifications under a fluorescence microscope, and image acquisition and analysis were performed to determine the localization of the oligonucleotides in the cells.
[0070] The present invention and its embodiments are described above, and such description is not restrictive. The drawings show only one embodiment of the present invention, and the actual structure is not limited thereto. In short, if ordinary technicians in the field are inspired by it, without departing from the purpose of the invention, they can design a structure and embodiment similar to the technical solution without creativity, which should belong to the protection scope of the present invention.
Claims
1. A fluorescence in situ hybridization method based on cell slides, characterized in that: The specific steps include: Step S1: Cell seeding: Inoculate cells in a 12-well cell plate covered with a round glass slide in advance; for primary cells, perform cell sorting one day in advance and then seed them in a 12-well cell plate; Step S2: Washing: The next day, discard the cell culture medium and slowly wash with 0.1% PBST three times, 5 minutes each time, to remove impurities and residues on the cell surface; Step S3: Fixation: Add 4% PFA for 30 minutes, then discard the 4% PFA and wash three times with 0.1% PBST for 5 minutes each time to fix the cell morphology; Step S4: Permeabilization: Add 0.3% Triton X-100 for 20 minutes, then discard 0.3% Triton X-100 and wash with 0.1% PBST for 3 times, 5 minutes each time, so that the probe can enter the cells smoothly; Step S5: Prehybridization: Add HYB- and incubate at 55°C for 5 minutes to remove nonspecific binding sites in the cells; Step S6: Hybridization: discard HYB-, add HYB+, incubate at 55°C for 3 hours, then add the probe prepared with HYB+, incubate at 55°C overnight to allow the probe to specifically bind to the target sequence in the cell; Step S7: Washing and sealing The next day, the probe was recovered, 50% acetamide-2×SSCT was added, and the mixture was incubated at 55°C for 30 minutes, and the process was repeated once; 2×SSCT was then incubated at 55°C for 15 minutes; 0.2×SSCT was added, and the mixture was incubated at 55°C for 30 minutes, and the process was repeated once; Blocking: Add 2% goat serum and block at room temperature for 15 minutes to block nonspecific binding sites; Step S8: Antibody incubation Primary antibody incubation: Add primary antibody prepared with 2% goat serum and incubate overnight at 26 rpm on a shaker at 4°C. The next day, take out the sample in advance and equilibrate and rewarm for 10 minutes. Recovery of primary antibody: After recovery of primary antibody, wash three times with 0.1% PBST, 10 minutes each time; Secondary antibody incubation: Dilute the corresponding host-derived fluorescent secondary antigen solution, DAPI and 2% goat serum according to the ratio specified in the instructions, mix well and add to the sample wells, and incubate at room temperature on a light-proof shaker at 26 rpm for 2 hours; Step S9: Washing and sealing: After recovering the secondary antibody, wash with 0.1% PBST for 3 times, 10 minutes each time; add anti-quenching agent for sealing to protect the sample and prevent fluorescence quenching; Step S10: Observation and analysis: Observation at different magnifications under a fluorescence microscope, and image acquisition and analysis were performed to determine the localization of the oligonucleotides in the cells.
